InsiderTrades

Form 4 for UTHR UNITED THERAPEUTICS Corp

Accepted 2025-09-10 00:00:00 ET · period of report 2025-09-09 · accession 0001106578-25-000003 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DMT 2025-09-10 2025-09-09 UTHR ROTHBLATT MARTINE A COB, CEO, Dir S - Sale+OE $398.55 -8,000 1,965 -80% -$3.19M
DT 2025-09-10 2025-09-09 UTHR ROTHBLATT MARTINE A COB, CEO, Dir M - OptEx $120.26 +8,000 8,130 +6,154% +$962.1K
DT 2025-09-10 2025-09-09 UTHR ROTHBLATT MARTINE A COB, CEO, Dir M - OptEx $0.00 -8,000 286.0K -3% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-09-09 S D 1,835 $399.43 130 D — — (F3) This transaction was executed in multiple trades at prices ranging from $398.92 to $399.485. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
2 Common Common Stock 2025-09-09 S D 6,165 $398.29 1,965 D — — (F2) This transaction was executed in multiple trades at prices ranging from $397.89 to $398.70. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
3 Common Common Stock 2025-09-09 M A 8,000 $120.26 8,130 D — —
4 Derivative Stock Option 2025-09-09 M D 8,000 $0.00 286,000 D $120.26 · 2016-03-15 to 2026-03-15 8,000 Common Stock